Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests using convalescent plasma to treat COVID-19 Long Hauler Syndromes because it may contain beneficial elements that target the virus.

The Covishield COVID-19 vaccine caused skin-related side effects in 1.23% of the people vaccinated in the study from India.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

COVID-19 can cause hair and nail disorders after infection.

COVID-19 doesn't make alopecia areata worse.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

COVID-19 infection may trigger alopecia areata in some patients.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

COVID-19 can cause hair loss, and managing it involves counseling, diet changes, and treatments.

Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.

Convalescent Plasma Therapy may help treat COVID-19 Long-Hauler symptoms.

COVID-19 can cause temporary hair loss.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

COVID-19 can cause long-term lung, skin, and mental health problems, especially in women, people with other health issues, and those who had severe COVID-19.

COVID-19 can cause skin problems in children.

COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.

The ACE1 gene variant doesn't affect long-COVID symptoms.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

Frankincense may help treat COVID-19, but more research is needed.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Rosemary oil and minoxidil 2% both effectively increase hair count in people with androgenetic alopecia, but rosemary oil causes less scalp itching.

Hair transplant techniques have improved and become less invasive over time, but there are concerns about unregulated centers. The market is growing, with potential for more growth in India due to increasing hair loss cases. New technologies like robotic transplants are promising for the future. Surgeons are encouraged to prioritize patient safety and understand the science behind their techniques.

Long-lasting COVID-19 symptoms like fatigue and breathing difficulties can persist for over 60 days, requiring ongoing care.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.